Search Results

Site Search

Diagnostic and companion testing - Insights

Learn more about how diagnostic and companion testing can confirm a prenatal genetic diagnosis.

Lysosomal metabolism and storage disorders - Insights

Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can clarify diagnosis of a lysosomal metabolism and storage disorder.

Other testing - Insights

Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.

Organic acid disorders - Insights

Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.

Coccidioides - Insights

Mayo Clinic Laboratories upfront, screening enzyme-linked immunosorbent assay detects Coccidioides antibodies prior to testing by complement fixation (CF) or immunodiffusion (ID). Samples that result as reactive by are subsequently reflexed...

Rare diseases - Insights

Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...

Monogenic IBD Testing - Mayo Clinic Laboratories

Monogenic inflammatory bowel disease (IBD) refers to a diverse spectrum of rare genetic disorders that present with intestinal inflammation. The majority of patients with monogenic IBD, unlike those with polygenic IBD, show symptoms before...

Breast Pathology Services at Mayo Clinic Laboratories

Given our case volume, we've developed a special expertise in those rare variants of carcinoma, where the diagnosis is essential. Learn more.

New Tests Launched Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Hereditary Oncology Testing [Test in Focus] - Insights

Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant...